We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 24, 2020

Racial and Ethnic Differences in Biomarkers and Cardiac Remodeling in Patients With HFrEF Treated With Sacubitril/Valsartan

Circulation: Heart Failure

 

Additional Info

Circulation: Heart Failure
Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan
Circ Heart Fail 2020 Oct 03;[EPub Ahead of Print], NE Ibrahim, IL Piña, A Camacho, D Bapat, GM Felker, AS Maisel, J Butler, MF Prescott, CA Abbas, SD Solomon, JL Januzzi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading